In last trading session, Cg Oncology Inc (NASDAQ:CGON) saw 2.01 million shares changing hands with its beta currently measuring 0.77. Company’s recent per share price level of $24.17 trading at -$0.01 or -0.04% at ring of the bell on the day assigns it a market valuation of $1.84B. That closing price of CGON’s stock is at a discount of -67.44% from its 52-week high price of $40.47 and is indicating a premium of 38.77% from its 52-week low price of $14.80. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.99 million shares which gives us an average trading volume of 1.31 million if we extend that period to 3-months.

For Cg Oncology Inc (CGON), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.20. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.45 in the current quarter.

Cg Oncology Inc (NASDAQ:CGON) trade information

Upright in the red during last session for losing -0.04%, in the last five days CGON remained trading in the green while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $24.17 price level, adding 6.35% to its value on the day. Cg Oncology Inc’s shares saw a change of -15.73% in year-to-date performance and have moved 8.19% in past 5-day. Cg Oncology Inc (NASDAQ:CGON) showed a performance of 20.49% in past 30-days. Number of shares sold short was 11.22 million shares which calculate 5.94 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 55 to the stock, which implies a rise of 56.05% to its current value. Analysts have been projecting 55 as a low price target for the stock while placing it at a high target of 55. It follows that stock’s current price would drop -127.55% in reaching the projected high whereas dropping to the targeted low would mean a loss of -127.55% for stock’s current value.

Cg Oncology Inc (CGON) estimates and forecasts

This year revenue growth is estimated to fall -59.68% from the last financial year’s standing.

6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 112.28k for the same. And 6 analysts are in estimates of company making revenue of 114.28k in the next quarter. Company posted 111k and 43k of sales in current and next quarters respectively a year earlier.

In 2025, company’s earnings growth rate is likely to be around -34.35% while estimates for its earnings growth in next 5 years are of 32.52%.

Cg Oncology Inc (NASDAQ:CGON)’s Major holders

Insiders are in possession of 1.17% of company’s total shares while institution are holding 100.31 percent of that, with stock having share float percentage of 101.50%. Investors also watch the number of corporate investors in a company very closely, which is 100.31% institutions for Cg Oncology Inc that are currently holding shares of the company. DECHENG CAPITAL LLC is the top institutional holder at CGON for having 5.46 million shares of worth $172.33 million. And as of 2024-06-30, it was holding 8.1903 of the company’s outstanding shares.

The second largest institutional holder is TCG CROSSOVER MANAGEMENT, LLC, which was holding about 3.67 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.5067 of outstanding shares, having a total worth of $115.87 million.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 1.89 shares of worth $45.59 million or 2.47% of the total outstanding shares. The later fund manager was in possession of 1.56 shares on Dec 31, 2024 , making its stake of worth around $37.71 million in the company or a holder of 2.05% of company’s stock.